comparemela.com
Home
Live Updates
Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan : comparemela.com
Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan
/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...
Related Keywords
United States ,
Boston ,
Massachusetts ,
Japan ,
China ,
Kohei Shitara ,
Valerie Malyvanh Jansen ,
National Cancer Center Hospital ,
Department Of Gastrointestinal Oncology ,
Prnewswire Elevation Oncology Inc ,
Corporate Communications Investor Relations ,
Nasdaq ,
Elevation Oncology Inc ,
Exchange Commission ,
Chief Medical Officer ,
Gastrointestinal Oncology ,
National Cancer Center Hospital East ,
Elevation Oncology ,
Private Securities Litigation Reform Act ,
Oncology Investor ,
Corporate Communications ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Pharmaceuticals ,
Clinical Trials Amp Medical Discoveries ,
comparemela.com © 2020. All Rights Reserved.